Company Data

INmune Bio Inc.

Ticker
INMB
Current Price
$9.245 -0.59%
Market Cap
$205.0M
Price Target
Refer to Report
Volume
141.7K
52wk Range
$4.32 - $14.74
Advanced Market Data

Overview

INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient’s innate immune system to allow the immune system to fight cancer. The company’s pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy